Merck

Vaxneuvance

ASP | WAC | AWP at the HCPCS Unit

Manufacturer:

Merck

Vaxneuvance HCPCS:

90671

HCPCS Code Descriptor:

PNEUMOCOCCAL CONJUGATE VACCINE, 15 VALENT (PCV15), FOR INTRAMUSCULAR USE

Category:

CPT Drug Code

Vaxneuvance NDCs:

00006-4329-02, 00006-4329-03

Primary Type:

Vaccine

Generic/Specialty Status:

Single-Source

Package Type:

Not Found

Route of Administration:

Intramuscular

Vaxneuvance CPT Codes:

Potential CPT administration codes for Vaxneuvance can be found at the following link.

Potential NDC Listing Errors:

Our team has identified potential listing errors/discrepancies with the following NDCs:

00006-4329-02, 00006-4329-03

About Vaxneuvance:

Vaxneuvance is a Vaccine drug manufactured by Merck and administered via the Intramuscular route of administration. The CPT Drug Code: 90671 is aligned to the drug Vaxneuvance.

ACCESS PRICING AND MORE BY REGISTERING

90671 Added Date:

NA

90671 Effective Date:

NA

90671 Termination Date:

HCPCS Active

We have not yet identified a manufacturer source of Vaxneuvance billing and coding information.
Vaxneuvance patient assistance information can be found through the Merck Helps Program at the URL: http://www.merckhelps.com/
Vaxneuvance prescribing information can be found at the link below:
Information regarding Vaxneuvance’s side effects can be found at MedlinePlus